KOPANS MODIFIED BREAST LESION LOCALIZATION NEEDLE DKBL-20-9.0-A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2018-08-08 for KOPANS MODIFIED BREAST LESION LOCALIZATION NEEDLE DKBL-20-9.0-A manufactured by Cook Inc.

Event Text Entries

[116480633] Pma/510(k) #: preamendment. (b)(4). This report includes information known at this time. A follow up report will be submitted should additional relevant information become available.
Patient Sequence No: 1, Text Type: N, H10


[116480634] It was reported between the time a kopans modified breast lesion localization needle was placed and the scheduled procedure, the marker moved. Due to the lesion not clearly identified, resection was "irradical" and the scheduled intraoperative radiation therapy (iort) led to a re-operation. Translation of further information indicated: "small tumor mass recognizable by a small calcification mark, patient had a large commuting mom and a lot of fat and a small tumor, ingredients for dislocation. The wire is placed with the tip through the mass, but the barb still hangs in the greasy tissue: m. I. Then more likely dislocation in this single barb. We almost always place under ultrasound guide, where the tip of the needle is placed just 1-5 mm through the mass and then under echo view the wire is held in place while the needle is retracted. When masking the wire, after mammographically documenting correct position cc and lm, the thread is rolled up externally loosely and taped off with fixomul, in patients with skin that is suitable for this, not quick wounds or rashes in plasters with transparent plastic ( 'second skin', product name escaped me). Localizations take place at the end of the afternoon, patients go to the hospital for a night and are operated on during the next day. " the radiologist further reported "this was really an unfortunate coincidence, namely big, fat, commuting mamma, little tumor, unfamiliarity with this temporary thread that is less easily attached to the tumor than the x-reidy, which we all know for decades and which never really come shallower or deeper to lie after placing through a 4-double barb. An additional problem with the patient was that the x-specimen was unjustly assessed as 'successful excision', as a result of which iort continued and only after the pa of the resection sample showed that an incomplete excision had been done and the patient ultimately had to have an ablation: after iort there is no way back to sparing treatment. "
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1820334-2018-02270
MDR Report Key7764652
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2018-08-08
Date of Report2018-10-08
Date of Event2018-07-16
Date Mfgr Received2018-10-01
Device Manufacturer Date2018-05-31
Date Added to Maude2018-08-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. LARRY POOL
Manufacturer Street750 DANIELS WAY
Manufacturer CityBLOOMINGTON IN 47404
Manufacturer CountryUS
Manufacturer Postal47404
Manufacturer Phone8123392235
Manufacturer G1COOK INC.
Manufacturer Street750 DANIELS WAY
Manufacturer CityBLOOMINGTON IN 47404
Manufacturer CountryUS
Manufacturer Postal Code47404
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameKOPANS MODIFIED BREAST LESION LOCALIZATION NEEDLE
Generic NameMIJ NEEDLE, TUMOR LOCALIZATION
Product CodeMIJ
Date Received2018-08-08
Model NumberNA
Catalog NumberDKBL-20-9.0-A
Lot Number8920426
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCOOK INC
Manufacturer Address750 DANIELS WAY BLOOMINGTON IN 47404 US 47404


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-08-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.